Literature DB >> 12390059

The spectrum of pseudomembranous enterocolitis and antibiotic-associated diarrhea.

Brian W Hurley1, Cuong C Nguyen.   

Abstract

Pseudomembranous (entero)colitis is primarily caused by Clostridium difficile infection. The most common predisposing factor is prior use of antibiotics, including vancomycin and metronidazole, which themselves are therapy for C difficile colitis. Other risk factors have also been described. The presence of C difficile in the gastrointestinal tract leads to a spectrum of manifestations from the asymptomatic carrier state to fulminant colitis. Successful treatment of C difficile colitis requires prompt treatment with appropriate antibiotics, withdrawal of the suspected predisposing antibiotics, and, in rare cases, total colectomy. Preventive measures of adequate infection control and judicious use of antibiotics are necessary means in attempting to control the spread of C difficile infection. Attempts at making an effective human vaccine are currently under way.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12390059     DOI: 10.1001/archinte.162.19.2177

Source DB:  PubMed          Journal:  Arch Intern Med        ISSN: 0003-9926


  41 in total

Review 1.  Review of medical and surgical management of Clostridium difficile infection.

Authors:  B Faris; A Blackmore; N Haboubi
Journal:  Tech Coloproctol       Date:  2010-05-08       Impact factor: 3.781

Review 2.  Pathology of drug-associated gastrointestinal disease.

Authors:  Ashley B Price
Journal:  Br J Clin Pharmacol       Date:  2003-11       Impact factor: 4.335

Review 3.  Biopsy interpretation of colonic biopsies when inflammatory bowel disease is excluded.

Authors:  Tze S Khor; Hiroshi Fujita; Koji Nagata; Michio Shimizu; Gregory Y Lauwers
Journal:  J Gastroenterol       Date:  2012-02-10       Impact factor: 7.527

Review 4.  Clostridium difficile causing acute renal failure: case presentation and review.

Authors:  Jasmin Arrich; Gottfried-H Sodeck; Gurkan Sengolge; Christoforos Konnaris; Marcus Mullner; Anton-N Laggner; Hans Domanovits
Journal:  World J Gastroenterol       Date:  2005-02-28       Impact factor: 5.742

Review 5.  Clostridium difficile toxins: mechanism of action and role in disease.

Authors:  Daniel E Voth; Jimmy D Ballard
Journal:  Clin Microbiol Rev       Date:  2005-04       Impact factor: 26.132

Review 6.  Pathogenesis and treatment of Clostridium difficile infection.

Authors:  I Tonna; P D Welsby
Journal:  Postgrad Med J       Date:  2005-06       Impact factor: 2.401

7.  Clostridium difficile: The evolving story.

Authors:  Bl Johnston; Jm Conly
Journal:  Can J Infect Dis Med Microbiol       Date:  2007-11       Impact factor: 2.471

8.  Efficacy assessment of two antibiotic prophylaxis regimens in oral and maxillofacial trauma surgery: preliminary results.

Authors:  Giordano Bp Campos; Eudes Es Lucena; José Sandro P da Silva; Petrus P Gomes; Adriano R Germano
Journal:  Int J Clin Exp Med       Date:  2015-02-15

9.  Clostridium difficile colitis.

Authors:  Judith L Trudel
Journal:  Clin Colon Rectal Surg       Date:  2007-02

10.  Ulcerative proctitis.

Authors:  Charles B Whitlow
Journal:  Clin Colon Rectal Surg       Date:  2004-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.